Clinical Nutrition Market Size, Share, and Growth Forecast for 2025 - 2032

Clinical Nutrition Market Size and Trends

The global clinical nutrition market is estimated to reach a size of US$ 44.1 Bn in 2025. It is predicted to exhibit a CAGR of 7.2% through the assessment period to attain a value of US$ 73.1 Bn by 2032.

Increasing emphasis on tailored dietary solutions based on individual health needs and genetic profiles are propelling growth. Rapid growth of nutritional genomics is predicted to bolster product development.

Integration of digital health technologies, including mobile health apps and telemedicine, are facilitating personalized dietary recommendations. The industry is turning to AI and data analytics for enhanced patient outcomes.

• The enteral nutrition segment is predicted to showcase a CAGR of 17.1% through 2032 owing to its widespread use in hospitals and homecare settings for critically ill patients.

Key Highlights of the Market

• Pediatric nutrition, including infant formulae, is witnessing growth owing to high prevalence of malnutrition and premature births worldwide, especially in developing nations.
• Demand for geriatric nutrition solutions that treat age-related health concerns like sarcopenia, osteoporosis, and cognitive loss are increasing rapidly.
• Enteral nutrition provides a less invasive alternative to parenteral techniques and hence is the most common route of administration for critically sick patients.
• Based on route of administration, the oral segment is predicted to hold a share of 54% in 2025 owing to their ease of administration.
• The COVID-19 pandemic emphasized the need of nutrition in immunological health, resulting in increased demand for therapeutic nutrition products.
• By application, the cancer segment is anticipated to hold a share of 17% in 2025 as the global burden of cancer surges.
• Asia Pacific is anticipated to lead with a share of 28% in 2025 owing to high malnutrition rates and increased healthcare infrastructure investments.

Global Market Attributes	Key Insights
Clinical Nutrition Market Size (2025E)	US$ 44.1 Bn
Market Value Forecast (2032F)	US$ 73.1 Bn
Projected Growth (CAGR 2025 to 2032)	7.2%
Historical Market Growth (CAGR 2019 to 2024)	6.7%

Historical Growth and Course Ahead

Enteral and Parenteral Nutrition Saw High Demand Amid COVID-19 from Patients in ICU

The global clinical nutrition market growth was steady at a CAGR of 6.7% in the historical period. The COVID-19 pandemic increased the demand for enteral and parenteral nutrition in intensive care units. Use of nutritional products and oral supplements at home was fueled by increased consumer attention to immunity and preventative health during the same period.

Developments in tailored nutrition along with an increasing prevalence of chronic diseases fostered growth. While plant-based nutrition and allergen-free products satisfy changing consumer tastes, innovations like customized nutritional solutions based on genetics, metabolism, and lifestyle characteristics are poised to completely transform the market.

Emergence of Plant-based Products with Surging Veganism to Push Growth through 2032

The industry is predicted to witness a CAGR of 7.2% through the forecast period. Popularity of plant-based diets and veganism is set to increase the demand for plant-based therapeutic nutrition products. This indicates a shift in consumer preferences toward sustainable and ethical dietary options.

Several people prefer plant-based foods for their health benefits. In response, producers are creating plant-based formulae, like protein supplements derived from pea, soy, or almonds, as well as allergen-free options. For instance,

• In January 2023, Nutricia announced the release of its first plant-based, ready-to-drink oral nutritional supplement, Fortimel® PlantBased Energy. This is specifically designed to address the nutritional needs of people who are malnourished or at risk of malnutrition due to sickness.

The oral nutritional supplement is nutritionally balanced, containing a blend of high-quality plant protein derived from pea and soy sources. It is appropriate for vegan, vegetarian, or flexitarian diets, as well as people with cow's milk protein allergies. 

Market Dynamics

Growth Drivers

Rising Cases of Anemia to Augment the Need for Fortified Nutritional Products 

Increasing awareness among consumers and healthcare providers regarding certain nutritional deficiencies is propelling growth. For instance, vitamin D supplementation is widely recommended by healthcare experts, especially for older adults, pregnant women, and people who have had limited sun exposure. This has further increased demand for fortified nutritional products and supplements designed specifically for these groups.

• According to a 2023 study by the Institute for Health Metrics and Evaluation (IHME), one-fourth of the global population is believed to be anemic, with cases rising quickly among women, pregnant mothers, young girls, and children under the age of five.
• In 2021, anemia impacted about 2 billion people, disproportionately affecting women. Anemia is the third greatest cause of years with living disability (YLD) worldwide.
• In 2023, the Chinese National Medical Products Administration (NMPA) approved Ferinject®, an intravenous iron therapy preparation for treating iron deficiency in adult patients for whom oral iron preparations are unsuccessful, according to a statement released by CSL Vifor and Fresenius Kabi.

China has the world's largest iron deficiency anemia population, with an estimated prevalence of 15%. This approval is predicted to improve the country’s healthcare system in a variety of ways, including the implementation of effective Patient Blood Management (PBM).

Market Restraining Factors

Clinical Nutrition Products May Cause Adverse Effects or Complications in Patients, Limiting Use

Adverse effects and difficulties associated with clinical nutrition products market pose a significant barrier to their widespread use. While these products are meant to address specific dietary requirements, incorrect formulation or delivery might result in unexpected consequences, especially in vulnerable populations like juvenile, geriatric, or critically sick patients. Allergic responses are also a problem, especially for items containing allergens like soy, lactose, gluten, or casein.

The potential of nutrient imbalances is another significant restraint, which can occur when vitamins, minerals, or electrolytes are overs supplemented. For example, a disproportionate amount of protein in people with impaired kidney function can deteriorate kidney function, and an excessive amount of iron might be hazardous. Such issues need careful product design and thorough monitoring by healthcare providers, which may limit the use of clinical nutrition products market in homecare settings or areas with inadequate medical oversight, impeding market expansion.

Key Market Opportunities

Metabolic Factors to Influence Customized Nutrition Strategies for Disease Management

Innovations in nutrigenomics, which analyze the interaction between genes and nutrition, have resulted in the creation of customized dietary therapies tailored to individual needs. Metabolic variables like insulin resistance or lipid metabolism disorders can alter dietary requirements. Personalized nutrition regimens can help in managing diabetes and cardiovascular disease by optimizing dietary intake.

Lifestyle factors like physical activity, stress, sleep, and dietary preferences influence individual nutritional requirements. As consumers become health-conscious and seek individualized approaches to their well-being, the market for genetic, metabolic, and lifestyle-based nutrition solutions is estimated to witness rapid growth. This surge is predicted to create considerable growth opportunities for clinical nutrition providers. For example,

• In January 2024, Abbott Laboratories launched a new protein shake designed to help adults reduce weight while maintaining muscle mass. According to the company, the protein drink is the first of several products set to launch under its new brand, Protality.

Clinical Nutrition Market Insights and Trends

Types of Clinical Nutrition Insights

Surging Cases of Children Malnutrition is Raising Demand for Pediatric Nutrition

Pediatric nutrition is predicted to exhibit a CAGR of 7.5% through 2032. High frequency of malnutrition, early deliveries, and increased awareness of child health are key factors driving growth.

• According to a report published by UNICEF in 2024, 181 million children under the age of 5 worldwide, or one out of every four, live in severe child food poverty, putting them up to 50 percent more likely to suffer a life-threatening form of malnutrition.

Emerging economies, where malnutrition rates remain high, witness a considerable demand for pediatric nutrition products, which are frequently backed by government initiatives and non-governmental organizations (NGOs). Infant formulas are showcasing high demand as these supply vital nutrients for optimum growth and development in children who cannot entirely breastfeed.

Developments in specialized pediatric formulation cater to children with specific medical ailments, like metabolic abnormalities, allergies, or gastrointestinal problems. These specialized products promote appropriate nutrition and recovery rates. Rising parental knowledge of the significance of balanced nutrition, particularly in the first 1,000 days of life, is driving demand.

Route of Administration Insights

Enteral Route of Administration is Effective in Delivering Essential Nutrients Directly to Gastrointestinal Tract

Enteral mode of administration is predicted to dominate with a CAGR of 7.7% through 2032. Its ability to provide critical nutrients directly to the GI tract fosters adoption. This approach is commonly used for patients who are unable to eat orally but have a functional digestive system.

Enteral nutrition is less intrusive than parenteral procedures and has a lower risk of problems like infections or metabolic imbalances. It is hence a preferred option in hospitals and homecare settings. Availability of various enteral feeding formulae customized to specific illnesses, like diabetes, cancer, or gastrointestinal issues, accelerates their use.

Novel delivery methods like feeding pumps and portable devices improve patients' convenience and safety in clinical and homecare settings. For instance,

• In September 2024, Nutricia, a subsidiary of Danone, a renowned food and beverage company, announced the launch of its reformulated Nutrison core range tube feeds.
• Nutrison is the company's best-selling adult medical nutrition brand, manufacturing specialized tube feeds designed to combat malnutrition in patients who are unable to eat or drink normally.

Regional Insights and Trends

Aging Population in North America to Spur Need for Osteoporosis and Sarcopenia Supplements

North America clinical nutrition market is predicted to hold a share of 32% in 2025. The region’s well-developed healthcare infrastructure, increasing knowledge of clinical nutrition, and rising prevalence of chronic diseases bolster growth.

• According to the U.S. Department of Health and Human Services, 129 million people in the U.S. have at least one significant chronic disease.

The aging population in North America is a key driver as the elderly population requires specialized nutritional supplements to treat illnesses like osteoporosis, sarcopenia, and cognitive loss. Clinical nutrition is essential to disease care, especially for patients receiving chemotherapy, managing diabetes, or recovering from surgery. For instance,

• In October 2024, Jaguar Health, Inc. announced that Napo Pharmaceuticals, a Jaguar family company, has begun commercialization of the FDA-approved oral mucositis prescription medicine Gelclair in the U.S.

Oral mucositis is one of the most common, painful, and debilitating side effects of cancer treatment. Gelclair is a mechanical gel that adheres to the mucosal surface of the mouth and is used to manage and relieve pain. It covers and protects the oral mucosa, thereby promoting healing.

Rising Diabetes Cases in Asia Pacific with 140 Million Predicted by 2045 Spurring Demand for Medical Nutrition

Clinical nutrition market in Asia Pacific is anticipated to hold a share of 28% in 2025. Rising disposable income is driving demand for healthcare and nutrition products. Increasing lifestyle-related diseases like diabetes, obesity, and cardiovascular condition are prompting higher demand for clinical nutrition.

• According to the World Health Organization (WHO), the prevalence of diabetes in Asia Pacific is predicted to reach 140 million by 2045.

The region is witnessing a demographic shift with a growing elderly population. For instance,

• By 2030, over 20% of the population in countries like Japan and South Korea are predicted to be aged 65 and older, thereby increasing the need for specialized nutritional products.

Extensive Hospital Networks in Europe to Enhance Accessibility to Clinical Nutrition Products

Europe clinical nutrition market is predicted to hold a share of 26% in 2025. The region boasts a well-established healthcare system with high standards of medical care. It has an extensive network of hospitals and healthcare providers who facilitate the delivery of clinical nutrition products. For example,

• According to the European Commission (EU), 60% of adults in Europe are classified as overweight or obese, thereby driving the demand for clinical nutrition solutions.

Europe has one of the oldest populations, with projections indicating that by 2040, over 30% of the population in a few countries will be aged 65 or older. This demographic shift increases the need for specialized nutritional support for age-related health issues.

Clinical Nutrition Market Competitive Landscape

Companies in the clinical nutrition market are highly competitive, with prominent competitors based in areas with strong healthcare systems and cutting-edge research capacities. Businesses from North America and Europe are predicted to dominate the market owing to their established distribution networks, varied product portfolios, and strong emphasis on innovation. These players leverage cutting-edge technologies to create specific nutrition solutions for chronic conditions, pediatric care, and geriatric needs.

As companies extend their online presence, clinical nutrition products are becoming widely available. The emergence of e-commerce has raised direct-to-consumer sales in the industry. Packaging innovations like portable feeding systems and ready-to-consume formats are another significant competitive tactic. The market is becoming more consolidated as partnerships, mergers, and acquisitions allow businesses to broaden their geographic reach and diversify their holdings.

Recent Industry Developments

• In November 2024, Cadila Pharmaceuticals launched Militol, a new iron supplement designed to give a precise balance of nutrients that increase absorption and tolerance, effectively treating iron insufficiency. Militol includes components that increase iron absorption and enhance one’s wellbeing.
• In September 2024, Dutch Medical Food B.V. and Pristine Pearl Pharma Pvt. Ltd. collaborated to transform patient care in India with the launch of groundbreaking medical nutrition solutions. The newly announced products are primarily aimed at illnesses like cancer, pediatric malnutrition, COPD, and drug-resistant epilepsy, to improve health outcomes throughout India.
• In May 2024, Danone announced a €70 Mn investment in its first production facility in France, focusing on medical nutrition. Majority of this investment will be used to create approximately 30 techniques for Danone's oral nutritional supplement for patients. The Steenvoorde location will provide 20 million liters of medicinal nutrition per year, improving results and quality of life for patients suffering from disease-related malnutrition.
• In May 2024, Centrum launched a health program called 'Your Nutrition Matters.’ The project emphasized the relevance of multivitamins in correcting micronutrient deficiencies and encouraging a healthy lifestyle in India. Their goal is to educate Indians about their Recommended Dietary Allowances (RDAs) and the need of including multivitamins in their daily meals.
• In October 2023, Nutricia, a division of the well-known international food and beverage corporation Danone, announced the release of its first medical nutrition drink, which is designed to help children with disease-related malnutrition and stunted growth. It contains a balanced blend of real fruit and vegetable ingredients.

Clinical Nutrition Market Report Scope

Report Attributes	Details
Historical Data/Actuals	2019 – 2024
Forecast Period	2025 - 2032
Market Analysis Units	Value: US$ Bn/Mn, Volume: As applicable
Geographical Coverage	North America Europe East Asia South Asia and Oceania Middle East and Africa Latin America
Segmental Coverage	Types of Clinical Nutrition Route of Administration Form Application Region
Competitive Analysis	Abbott             Baxter             Nestlé Health Science S.A.                 Perrigo Company PLC                       B. Braun      Danone                        Reckitt Benckiser                   Ajinomoto                   Hero Nutritionals                    PFIZER INC               BASF Corporation                  Bayer AG                    Fresenius Kabi                        Grifols             Mead Johnson & Company                MediFood International                      Sanofi              Lonza's Capsules & Health                Others
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Pricing Analysis & Technology Roadmap Future Opportunities and Revenue Pockets Industry Market Analysis Tools
Customization and Pricing	Available upon request

Clinical Nutrition Market Segmentation

By Types of Clinical Nutrition  

• Pediatric Nutrition                 
• Oncology Nutrition               
• Geriatric Nutrition                 
• Sports Nutrition                     
• Diabetes Management           
• Gastrointestinal Nutrition                  
• Others            

By Route of Administration

• Enteral
• Parenteral
• Oral
• Others

By Form

• Powder           
• Liquid
• Capsule/Tablets         
• Others

By Application

• Malnutrition               
• Cancer            
• Gastrointestinal Disorders                 
• Diabetes                     
• Neurological Conditions                    
• Cardiovascular Diseases                    
• Others            

By Region

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• The Middle East and Africa

To know more about delivery timeline for this report Contact Sales